下一个

自动播放

Dr. Yasmin Thanavala on targeted therapy for liver cancer

2 意见 • 06/28/23
分享
嵌入
administrator
administrator
订户
0

Yasmin Thanavala, PhD, of the Department of Immunology and the Tumor Immunology and Immunotherapy program at Roswell Park Cancer Institute, discusses new research that may help identify those patients with advanced liver cancer who will benefit most from the targeted therapy sorafenib. Read more: http://goo.gl/W0jPX2

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放